----

----

| Nevada                                    |   | 87-0479286                           |
|-------------------------------------------|--------|--------------------------------------|
| (State of jurisdiction of Incorporation)  |   | (I.R.S. Employer Identification No.) |
|                                      |   |                                 |
| 31 N. Suffolk Lane, Lake Forest, Illinois |   | 60045                                |
| (Address of principal executive offices)  |   | (Zip Code)                           |

----

|                        Large accelerated filer     o           | Accelerated filer                   o |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|
|                        Non-accelerated filer       o | Smaller reporting company  x                                                                                               |
|     (Do not check if a smaller reporting company)                                                                                                                                      |                                                                                                                                 |

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

| ITEM 3.  LEGAL PROCEDINGS |
|-------------------------------------|

----

|                         |   | Closing Bid Prices(1) |   |
|------------------------------|--------|-----------------------|--------|
|                         |   | High                  |   |   | Low |   |
|                         |   |                  |   |   |   |   |
|                         |   |                  |   |   |   |   |
| Year Ended December 31, 2010 |   |                  |   |   |   |   |
| 4th Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
| 3rd Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
| 2nd Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
| 1st Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
|                         |   |                  |   |   |   |   |   |   |
| Year Ended December 31, 2009 |   |                  |   |   |   |   |   |   |
| 4th Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
| 3rd Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
| 2nd Quarter                  |   | $                     | 0.10   |   |   | $ | 0.10 |   |
| 1st  Quarter       |   | $                     | 0.10   |   |   | $ | 0.10 |   |

----

----

----

----

----

|                                                                                                                                                                                                                                                                                                             |  Page            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------|
|  Report of Independent Registered Public Accounting Firm                                                                                                                                                                                                                                                    |  F-1             |
|  Balance Sheets, December 31, 2010, September 30, 2010 and 2009                                                                                                                                                                                                                                             |  F-2             |
|  Statements of Operations for the three months ended December 31, 2010 and 2009 (2009 unaudited),    for the years ended September 30, 2010 and 2009 and for the Period from May 27, 2004    Date of Inception of the Development Stage) through December 31, 2010  |    F-3 |
|  Statements of Stockholders’ Deficit for the Period from May 27, 2004 (Date of Inception of    the Development Stage) through September 30, 2007, for the Years Ended September 30, 2008,    2009 and 2010, and for the Three Months Ended December 31, 2010  |    F-4 |
|  Statements of Cash Flows for the three months ended December 31, 2010 and 2009 (2009 unaudited),    for the years ended September 30, 2010 and 2009 and for the Period from May 27, 2004    (Date of Inception of the Development Stage) through December 31, 2010 |    F-5 |
|  Notes to Financial Statements                                                                                                                                                                                                                                                                              |  F-6             |

----

| To the Board of Directors and the Shareholders |
|------------------------------------------------|

| Acquired Sales Corporation |
|----------------------------|

----

| ACQUIRED SALES CORP.                                 |
|------------------------------------------------------|
| (a development stage enterprise)                     |
| Balance Sheets                                       |
|                                                 |   |   |   |   |   |   |   |   |   |
|                                                 |   | December 31, |   |   | September 30, |   |
|                                                 |   | 2010 |   |   | 2010 |   |   | 2009 |   |
| ASSETS                                               |   |   |   |   |   |   |   |   |   |
| Current Assets:                                      |   |   |   |   |   |   |   |   |   |
| Cash                                                 |   | $ | 5,148 |   |   | $ | - |   |   | $ | 12 |   |
| Prepaid expense                                      |   |   | - |   |   |   | - |   |   |   | 25 |   |
| TOTAL ASSETS                                         |   | $ | 5,148 |   |   | $ | - |   |   | $ | 37 |   |
|                                                 |   |   |   |   |   |   |   |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIT                |   |   |   |   |   |   |   |   |   |   |   |   |
| Current Liabilities:                                 |   |   |   |   |   |   |   |   |   |   |   |   |
| Deficit in bank                                      |   | $ | - |   |   | $ | 46 |   |   | $ | - |   |
| Accounts payable                                     |   |   | 17,055 |   |   |   | 14,389 |   |   |   | 2,371 |   |
| Notes payable - related parties                      |   |   | 44,000 |   |   |   | 24,000 |   |   |   | 10,000 |   |
| Note interest payable - related party                |   |   | - |   |   |   | - |   |   |   | 82 |   |
| Total Current Liabilities                            |   |   | 61,055 |   |   |   | 38,435 |   |   |   | 12,453 |   |
|                                                 |   |   |   |   |   |   |   |   |   |   |   |   |
| Stockholders' Deficit:                               |   |   |   |   |   |   |   |   |   |   |   |   |
| Preferred stock, $0.001 par value, 10,000,000 shares |   |   |   |   |   |   |   |   |   |   |   |   |
| authorized, no shares issued and outstanding         |   |   | - |   |   |   | - |   |   |   | - |   |
| Common stock, $0.001 par value, 50,000,000 shares    |   |   |   |   |   |   |   |   |   |   |   |   |
| authorized, 5,832,482 shares issued and outstanding  |   |   | 5,833 |   |   |   | 5,833 |   |   |   | 5,833 |   |
| Additional paid-in capital                           |   |   | 454,754 |   |   |   | 145,967 |   |   |   | 145,967 |   |
| Deficit accumulated prior to the development stage   |   |   | (69,151 | ) |   |   | (69,151 | ) |   |   | (69,151 | ) |
| Deficit accumulated during the development stage     |   |   | (447,343 | ) |   |   | (121,084 | ) |   |   | (95,065 | ) |
| Total Stockholders' Deficit                          |   |   | (55,907 | ) |   |   | (38,435 | ) |   |   | (12,416 | ) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT          |   | $ | 5,148 |   |   | $ | - |   |   | $ | 37 |   |
|                                                 |   |   |   |   |   |   |   |   |   |   |   |   |
| See accompanying notes to the financial statements.  |

----

| ACQUIRED SALES CORP.                                |
|-----------------------------------------------------|
| (a development stage enterprise)                    |
| Statements of Operations                            |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   | For the period |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   | May 27, 2004 |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   | (Date of Inception |   |
|                                                |   | For the Three Months Ended |   |   | For the Years Ended |   |   | of the Development |   |
|                                                |   | December 31, |   |   | September 30, |   |   | Stage) through |   |
|                                                |   | 2010 |   |   | 2009 |   |   | 2010 |   |   | 2009 |   |   | December 31, 2010 |   |
|                                                |   |   |   |   | (Unaudited) |   |   |   |   |   |   |   |   |   |   |
| Expenses:                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| General and administrative                          |   | $ | (325,210 | ) |   | $ | (5,099 | ) |   | $ | (23,946 | ) |   | $ | (11,669 | ) |   | $ | (497,767 | ) |
| Waiver of tax liability penalty                     |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 60,364 |   |
| Interest                                            |   |   | (1,049 | ) |   |   | (407 | ) |   |   | (2,073 | ) |   |   | (667 | ) |   |   | (9,940 | ) |
| Net Loss                                            |   | $ | (326,259 | ) |   | $ | (5,506 | ) |   | $ | (26,019 | ) |   | $ | (12,336 | ) |   | $ | (447,343 | ) |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted loss per share                    |   | $ | (0.06 | ) |   | $ | (0.00 | ) |   | $ | (0.00 | ) |   | $ | (0.00 | ) |   |   |   |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted weighted average                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| common shares outstanding                           |   |   | 5,832,482 |   |   |   | 5,832,482 |   |   |   | 5,832,482 |   |   |   | 5,832,482 |   |   |   |   |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| See accompanying notes to the financial statements. |

----

| ACQUIRED SALES CORP.                                                                                      |
|-----------------------------------------------------------------------------------------------------------|
| (a development stage enterprise)                                                                          |
| Statements of Stockholders' Deficit                                                                       |
| for the Period from May 27, 2004 (Date of Inception of the Development Stage) through September 30, 2007, |
| for the Years Ended September 30, 2008, 2009 and 2010 and for the Three Months Ended December 31, 2010    |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   | Deficit |   |   | Deficit |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   | Accumulated |   |   | Accumulated |   |   | Total |   |
|                                                                                                      |   |   |   |   |   |   |   | Additional |   |   | Prior to the |   |   | During the |   |   | Stockholders' |   |
|                                                                                                      |   | Common Stock |   |   | Paid-in |   |   | Development |   |   | Development |   |   | Equity |   |
|                                                                                                      |   | Shares |   |   | Amount |   |   | Capital |   |   | Stage |   |   | Stage |   |   | (Deficit) |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, May 27, 2004 (Date of                                                                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Inception of the Development                                                                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Stage)                                                                                                    |   |   | 684,990 |   |   | $ | 685 |   |   | $ | (685 | ) |   | $ | (69,151 | ) |   | $ | - |   |   | $ | (69,151 | ) |
| Common stock issued for cash,                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| May 2004, $0.001 per share                                                                                |   |   | 4,000,000 |   |   |   | 4,000 |   |   |   | 36,000 |   |   |   | - |   |   |   | - |   |   |   | 40,000 |   |
| Common stock redeemed for                                                                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| cash, May 2004, $0.001                                                                                    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| per share                                                                                                 |   |   | (19,005 | ) |   |   | (19 | ) |   |   | (171 | ) |   |   | - |   |   |   | - |   |   |   | (190 | ) |
| Capital contributed by officer,                                                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| September 30, 2004                                                                                        |   |   | - |   |   |   | - |   |   |   | 20 |   |   |   | - |   |   |   | - |   |   |   | 20 |   |
| Conversion of note payable to                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| related party into common stock                                                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| July 2007, $0.086 per share                                                                               |   |   | 1,166,497 |   |   |   | 1,167 |   |   |   | 98,833 |   |   |   | - |   |   |   | - |   |   |   | 100,000 |   |
| Issuance of 175,000 warrants                                                                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| for services, August 2007,                                                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| $0.068 per warrant                                                                                        |   |   | - |   |   |   | - |   |   |   | 11,970 |   |   |   | - |   |   |   | - |   |   |   | 11,970 |   |
| Net loss through September 30, 2007                                                                       |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (48,023 | ) |   |   | (48,023 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, September 30, 2007                                                                               |   |   | 5,832,482 |   |   |   | 5,833 |   |   |   | 145,967 |   |   |   | (69,151 | ) |   |   | (48,023 | ) |   |   | 34,626 |   |
| Net loss                                                                                                  |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (34,706 | ) |   |   | (34,706 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, September 30, 2008                                                                               |   |   | 5,832,482 |   |   |   | 5,833 |   |   |   | 145,967 |   |   |   | (69,151 | ) |   |   | (82,729 | ) |   |   | (80 | ) |
| Net loss                                                                                                  |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (12,336 | ) |   |   | (12,336 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, September 30, 2009                                                                               |   |   | 5,832,482 |   |   |   | 5,833 |   |   |   | 145,967 |   |   |   | (69,151 | ) |   |   | (95,065 | ) |   |   | (12,416 | ) |
| Net loss                                                                                                  |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (26,019 | ) |   |   | (26,019 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, September 30, 2010                                                                               |   |   | 5,832,482 |   |   |   | 5,833 |   |   |   | 145,967 |   |   |   | (69,151 | ) |   |   | (121,084 | ) |   |   | (38,435 | ) |
| Stock Option Compensation                                                                                 |   |   | - |   |   |   | - |   |   |   | 308,787 |   |   |   | - |   |   |   | - |   |   |   | 308,787 |   |
| Net loss                                                                                                  |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (326,259 | ) |   |   | (326,259 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, December 31, 2010                                                                                |   |   | 5,832,482 |   |   |   | 5,833 |   |   |   | 454,754 |   |   |   | (69,151 | ) |   |   | (447,343 | ) |   |   | (55,907 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| See accompanying notes to the financial statements.                                                       |

----

| ACQUIRED SALES CORP.                                |   |
|-----------------------------------------------------|--------|
| (a development stage enterprise)                    |   |
| Statements of Cash Flows                            |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   | For the period |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   | May 27, 2004 |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   | (Date of Inception |   |
|                                                |   | For the Three Months Ended |   |   | For the Years Ended |   |   | of the Development |   |
|                                                |   | December 31, |   |   | September 30, |   |   | Stage) through |   |
|                                                |   | 2010 |   |   | 2009 |   |   | 2010 |   |   | 2009 |   |   | December 31, 2010 |   |
|                                                |   |   |   |   | (unaudited) |   |   |   |   |   |   |   |   |   |   |
| Cash Flows from Operating Activities:               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                            |   | $ | (326,259 | ) |   | $ | (5,506 | ) |   | $ | (26,019 | ) |   | $ | (12,336 | ) |   | $ | (447,343 | ) |
| Adjustments to reconcile net loss to net cash       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   used in operating activities:           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Expenses paid by capital contributed by officer     |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 20 |   |
| Share-based compensation                            |   |   | 308,787 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 308,787 |   |
| Waiver of tax liability penalty                     |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (60,364 | ) |
| Issuance of warrants for services                   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 11,970 |   |
| Changes in assets and liabilities:                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Prepaid expense                                     |   |   | - |   |   |   | 6 |   |   |   | 25 |   |   |   | (25 | ) |   |   | - |   |
| Accounts payable                                    |   |   | 2,666 |   |   |   | 1,893 |   |   |   | 12,018 |   |   |   | 1,621 |   |   |   | 17,055 |   |
| Note interest payable - related party               |   |   | - |   |   |   | (82 | ) |   |   | (82 | ) |   |   | 82 |   |   |   | - |   |
| Payroll tax penalties and accrued interest          |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (8,787 | ) |
| Net Cash Used by Operating Activities               |   |   | (14,806 | ) |   |   | (3,689 | ) |   |   | (14,058 | ) |   |   | (10,658 | ) |   |   | (178,662 | ) |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Cash Flows from Financing Activities:               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Deficit in bank                                     |   |   | (46 | ) |   |   | - |   |   |   | 46 |   |   |   | - |   |   |   | - |   |
| Proceeds from issuance of note payable to           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| related parties                                     |   |   | 20,000 |   |   |   | 10,000 |   |   |   | 14,000 |   |   |   | 10,000 |   |   |   | 239,000 |   |
| Payment of principal on note payable to             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| related parties                                     |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (95,000 | ) |
| Proceeds from issuance of common stock              |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 40,000 |   |
| Redemption of common stock                          |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (190 | ) |
| Net Cash Provided by Financing Activities:          |   |   | 19,954 |   |   |   | 10,000 |   |   |   | 14,046 |   |   |   | 10,000 |   |   |   | 183,810 |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net Increase (Decrease) in Cash                     |   |   | 5,148 |   |   |   | 6,311 |   |   |   | (12 | ) |   |   | (658 | ) |   |   | 5,148 |   |
| Cash at beginning of period                         |   |   | - |   |   |   | 12 |   |   |   | 12 |   |   |   | 670 |   |   |   | - |   |
| Cash at End of Period                               |   | $ | 5,148 |   |   | $ | 6,323 |   |   | $ | - |   |   | $ | 12 |   |   | $ | 5,148 |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental Cash Flow Information                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Cash paid for interest                              |   | $ | 1,049 |   |   | $ | 478 |   |   | $ | 2,155 |   |   | $ | 585 |   |   |   |   |   |
|                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| See accompanying notes to the financial statements. |   |

----

----

----

----

| Three Months Ended December 31, 2010 |   |   |
|--------------------------------------|--------|--------|
| Weighted-average volatility          |   | 77.88  | % |
| Expected dividends                   |   | 0      | % |
| Expected term (years)                |   | 5.20   |   |
| Risk-free interest rate              |   | 1.11   | % |

|                                                    |   |       |   |       |   |   | Weighted-    |   |   |       |   |
|---------------------------------------------------------|--------|------------|--------|------------|--------|--------|--------------|--------|--------|------------|--------|
|                                                    |   |       |   | Weighted - |   |   | Average      |   |   |       |   |
|                                                    |   |       |   | Average    |   |   | Remaining    |   |   | Aggregate  |   |
|                                                    |   |       |   | Exercise   |   |   | Contractual  |   |   | Instrinsic |   |
| Options                                                 | Shares |       |   | Price      |   |   | Term (Years) |   |   | Value      |   |
| Outstanding, October 1, 2010                            |   | -          |   |       | $      | -      |         |   |   |       |   |   |   |
| Granted during the three months ended December 31, 2010 |   | 12,600,000 |   |       |   | 0.10   |         |   |   |       |   |   |   |
| Outstanding, December 31, 2010                          |   | 12,600,000 |   |       | $      | 0.10   |         |   |   | 5.2        |   |   | $ | - |   |
| Exercisable, December 31, 2010                          |   | -          |   |       | $      | -      |         |   |   | -          |   |   | $ | - |   |

----

|                         |   | December 31, |     |   | September 30, |   |
|------------------------------|--------|--------------|----------|--------|---------------|--------|
|                         |   | 2010         |     |   | 2010          |   |   | 2009 |   |
| Warrants outstanding         |   | $            | -        |   |          | $      | 4,465 |   |   | $ | 4,465 |   |
| Stock option compensation    |   |         | 115,177  |   |          |   | - |   |   |   | - |   |
| Operating loss carryforwards |   |         | 148,026  |   |          |   | 37,098 |   |   |   | 28,252 |   |
| Total deferred tax assets    |   |         | 263,203  |   |          |   | 41,563 |   |   |   | 32,717 |   |
| Less: Valuation allowance    |   |         | (263,203 | )      |          |   | (41,563 | ) |   |   | (32,717 | ) |
|                         |   |         |     |   |          |   |   |   |   |   |   |   |
| Net Deferred Tax Asset       |   | $            | -        |   |          | $      | - |   |   | $ | - |   |

|                           |   | December 31, |     |   | September 30, |   |
|--------------------------------|--------|--------------|----------|--------|---------------|--------|
|                           |   | 2010         |     |   | 2010          |   |   | 2009 |   |
| Federal income tax benefit     |   |         |     |   |          |   |   |   |   |
|  at statutory rate of 34% |   | $            | (110,928 | )      |          | $      | (8,846 | ) |   | $ | (4,194 | ) |
| Change in valuation allowance  |   |         | 110,928  |   |          |   | 8,846 |   |   |   | 4,194 |   |
|                           |   |         |     |   |          |   |   |   |   |   |   |   |
| Provision for income taxes     |   | $            | -        |   |          | $      | - |   |   | $ | - |   |

----

| Assets                                                                          |   |   |     |
|---------------------------------------------------------------------------------|--------|--------|----------|
| Cash and total current assets                                                   |   | $      | 105,148  |   |
| Long-term 5% notes receivable from Cogility                                     |   |   | 820,000  |   |
| Total Assets                                                                    |   | $      | 925,148  |   |
| Liabilities and Stockholders' Equity                                            |   |   |     |   |
| Accounts payable                                                                |   | $      | 17,055   |   |
| Notes payable to related parties                                                |   |   | 44,000   |   |
| Total current liabilities                                                       |   |   | 61,055   |   |
| Long-term liabilities                                                           |   |   |     |   |
| 3% Notes payable to related parties; $400,000 face amount;                      |   |   |     |   |
|   less $132,828 unamortized discount based on effective interest |   |   |     |   |
|   rate of 14.0%                                                       |   |   | 267,172  |   |
| 3% Notes payable; $520,000 face amount; less $172,675                           |   |   |     |   |
|   unamortized discount based on effective interest rate of 11.9% |   |   | 347,325  |   |
| Total liabilities                                                               |   |   | 675,552  |   |
| Stockholders' equity                                                            |   |   |     |   |
| Common stock                                                                    |   |   | 5,833    |   |
| Additional paid-in capital                                                      |   |   | 760,257  |   |
| Deficit accumulated prior to the development stage                              |   |   | (69,151  | ) |
| Deficit accumulated during the development stage                                |   |   | (447,343 | ) |
| Total stockholders' equity                                                      |   |   | 249,596  |   |
| Total Liabilities and Stockholders' Equity                                      |   | $      | 925,148  |   |

----

| ·   | pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and disposition of an issuer; |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the issuer; and |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ·   | provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer's assets that could have a material adverse effect on the financial statements. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | There existed a lack of segregation of duties in regard to the Company’s financial reporting, procedures for depositing of funds, procedures for cash disbursements, procedures for checkbook entries, period close procedures, and procedures for financial statement preparation. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | During November 2009, the Company increased its Board of Directors to seven members, and added as an additional independent member Mr. Vincent J. Mesolella. Mr. Mesolella is the Chairman of the Narragansett Bay Commission, Providence, Rhode Island. Mr. Mesolella is also the Chief Executive Officer of REI, Inc., a diversified real estate development company. Mr. Mesolella has previously served as the Chairman of the Audit Committee of the Board of Directors of a publicly traded company. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Beginning in March 2009, the Company had begun emailing or mailing to Mr. Mesolella a copy of each monthly statement from its bank summarizing all activity in the Company’s checking account, for review and questioning as appropriate. The purpose of Mr. Mesolella’s involvement is to provide monitoring, oversight and assistance to Mr. Jacobs, our principal financial and executive officer in the preparation and reporting of the Company’s financial statements. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name                  |   | Age    |   | Position                                                           |
|-----------------------|--------|--------|--------|--------------------------------------------------------------------|
|                  |   |   |   |                                                               |
| Gerard M. Jacobs      |   | 55     |   | Chairman, chief executive officer, president, secretary, treasurer |
|                  |   |   |   |                                                               |
| Joshua A. Bloom, M.D. |   | 54     |   | Director                                                           |
|                  |   |   |   |                                                               |
| Roger S. Greene       |   | 55     |   | Director                                                           |
|                  |   |   |   |                                                               |
| James S. Jacobs, MD   |   | 56     |   | Director                                                           |
|                  |   |   |   |                                                               |
| Michael D. McCaffrey  |   | 64     |   | Director                                                           |
|                  |   |   |   |                                                               |
| Richard E. Morrissy   |   | 56     |   | Director                                                           |
|                  |   |   |   |                                                               |
| Vincent J. Mesolella  |   | 61     |   | Director                                                           |
|                  |   |   |   |                                                               |

----

----

----

----

----

----

|                    |   | Annual Compensation |   | Long-Term Compensation                                                                                                                   |
|-------------------------|--------|---------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------|
|                    |   |                |   |                                                                                                                                     |   |   |   |   |   |   |   | Common |   |   |
|                    |   |                |   |                                                                                                                                     |   |   |   |   |   |   |   | Shares |   |   |
|                    |   |                |   |                                                                                                                                     |   |   |   |   |   |   |   | Underlying |   | All |
|                    |   |                |   |                                                                                                                                     |   |   |   |   |   | Restricted |   | Options |   | Other |
|                    |   |                |   |                                                                                                                                     |   |   |   | Other Annual |   | Stock |   | Granted |   | Compensation |
| Name and Position       |   | Year                |   | Salary                                                                                                                                   |   | Bonus |   | Compensation |   | Awards |   | ($) |   |   |
|                    |   |                |   |                                                                                                                                     |   |   |   |   |   |   |   |   |   |   |
| Gerard M. JacobsCEO.(1) |   | 20102009            |   |     $ -          $ -       |   | - |   | - |   | - |   | $769,560(2) |   | - |

| (1)   | Mr. Jacobs has been issued options to purchase 12,100,000 shares of our common stock at a purchase price of $0.10 per share. These options will vest upon closing of the Cogility acquisition and expire on November 4, 2020. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | The weighted-average grant-date fair value of options granted during the three months ended December 31, 2010 was $0.0636 per share. The Company recognizes compensation expense for stock-based awards expected to vest on a straight-line basis over the requisite service period of the award based on their grant date fair value.  The Company estimates the fair value of stock options using a Black-Scholes option pricing model which requires management to make estimates for certain assumptions regarding risk-free interest rate, expected life of options, expected volatility of stock and expected dividend yield of stock. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Name                 | Fees earned or paid in cash ($) | Stock awards ($) | Option awards($)(1)(2) | Non-equity incentive plan compensation ($) | Nonqualified deferredcompensation earnings($) | All other compensation ($) | Total($) |
|----------------------|---------------------------------|------------------|------------------------|--------------------------------------------|-----------------------------------------------|----------------------------|----------|
| Gerard M. Jacobs(3)  | -                               | -                | -                      | -                                          | -                                             | -                          | -        |
| Joshua A. Bloom      | -                               | -                | $6,360                 | -                                          | -                                             | -                          | $6,360   |
| Roger S. Greene      | -                               | -                | $6,360                 | -                                          | -                                             | -                          | $6,360   |
| Michael McCaffrey    | -                               | -                | $6,360                 | -                                          | -                                             | -                          | $6,360   |
| Vincent J. Mesolella | -                               | -                | $6,360                 | -                                          | -                                             | -                          | $6,360   |
| Richard E. Morrissy  | -                               | -                | $6,360                 | -                                          | -                                             | -                          | $6,360   |
|                 |                            |             |                   |                                       |                                          |                       |     |   |

| (1)   | These options entitle the holder to purchase shares of our common stock at a purchase price of $0.10 per share. These options will vest upon closing of the Cogility acquisition and expire on November 4,2020. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | The weighted-average grant-date fair value of options granted during the three months ended December 31, 2010 was $0.0636 per share. The Company recognizes compensation expense for stock-based awards expected to vest on a straight-line basis over the requisite service period of the award based on their grant date fair value.  The Company estimates the fair value of stock options using a Black-Scholes option pricing model which requires management to make estimates for certain assumptions regarding risk-free interest rate, expected life of options, expected volatility of stock and expected dividend yield of stock. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3)   | Mr. Jacobs’ option compensation described in the preceding table is deemed to be executive compensation. |
|-----------------|----------------------------------------------------------------------------------------------------------------|

----

----

| Outstanding Equity Awards At Fiscal Year End(see description of columns (a) through (j) below) Option Awards                                                                                                                                              Stock Awards                                                                                                                                                                                                                                                                      |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|              (a)                               (b)               (c)           (d)            (e)           (f)             (g)                 (h)            (i)          (j)Gerard M. Jacobs, CEO   12,100,000        -               -          $0.10      11/4/20   12,100,000    $769,560  |

| (a)   | The name of the named executive officer (column (a)); |
|-----------------|-------------------------------------------------------|

| (b)   | On an award-by-award basis, the number of securities underlying unexercised options, including awards that have been transferred other than for value, that are exercisable and that are not reported in column (d) (column (b)); |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (c)   | On an award-by-award basis, the number of securities underlying unexercised options, including awards that have been transferred other than for value, that are unexercisable and that are not reported in column (d) (column (c)); |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (d)   | On an award-by-award basis, the total number of shares underlying unexercised options awarded under any equity incentive plan that have not been earned (column (d)); |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (e)   | For each instrument reported in columns (b), (c) and (d), as applicable, the exercise or base price (column (e)); |
|-----------------|-------------------------------------------------------------------------------------------------------------------|

| (f)   | For each instrument reported in columns (b), (c) and (d), as applicable, the expiration date (column (f)); |
|-----------------|------------------------------------------------------------------------------------------------------------|

| (g)   | The total number of shares of stock that have not vested and that are not reported in column (i) (column (g)); |
|-----------------|----------------------------------------------------------------------------------------------------------------|

| (h)   | The aggregate market value of shares of stock that have not vested and that are not reported in column (j) (column (h)); |
|-----------------|--------------------------------------------------------------------------------------------------------------------------|

----

| (i)   | The total number of shares of stock, units or other rights awarded under any equity incentive plan that have not vested and that have not been earned, and, if applicable the number of shares underlying any such unit or right (column (i)); and |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (j)   | The aggregate market or payout value of shares of stock, units or other rights awarded under any equity incentive plan that have not vested and that have not been earned (column (j)). |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name and Address                                  |   | Amount and Nature of Beneficial Ownership |   | Percent of Voting Securities |
|---------------------------------------------------|--------|-------------------------------------------|--------|------------------------------|
|                                              |   |                                      |   |                         |
| Leonard D. Hall (1)                               |   | 600,000                                   |   | 10.3%                        |
| Gerard M. Jacobs (2)                              |   | 19,666,497                                |   |  337.2%                 |
| Joshua A. Bloom, M.D. (3)                         |   | 100,000                                   |   |   1.7%             |
| Roberti Jacobs Family Trust (4)                   |   | 4,666,497                                 |   | 80.0%                        |
| Roger S. Greene (5)                               |   | 350,000                                   |   |   6.0%             |
| Michael D. McCaffrey (6)                          |   | 100,000                                   |   |   1.7%             |
| Richard E. Morrissy (7)                           |   | 100,000                                   |   |   1.7%             |
| Vincent J. Mesolella (8)                          |   | 350,000                                   |   |   6.0%             |
| Joseph S. Keller (9)                              |   | 3,000,000                                 |   | 51.4%                        |
| John and Susan Heider (10)                        |   | 1,500,000                                 |   | 25.7%                        |
| Total Officers and Directors as group (6 persons) |   | 19,781,497 (11)                           |   |                         |
|                                              |   |                                      |   |                         |

| (1)   | The address for Mr. Hall is 1029 E. 380 North, American Fork, Utah 84003. |
|-----------------|---------------------------------------------------------------------------|

| (2)   | The address for Mr. Jacobs is 31 N. Suffolk Lane, Lake Forest, Illinois 60045. Mr. Jacobs, our chairman, chief executive officer, president, secretary, and treasurer has voting control over 19,666,497 shares, consisting of: (a) 1,166,497 Company shares owned by the Roberti Jacobs Family Trust, over which Mr. Jacobs has voting control via a 2007 shareholders agreement; (b) 2,900,000 Company shares owned by unrelated shareholders of the Company, over which Mr. Jacobs has voting control via a 2007 shareholders agreement; (c) 12,100,000 options at $0.10 per share, the vesting of which is contingent upon the closing of the merger with Cogility; and (d) 3,500,000 warrants at $0.10 per share, owned by the Roberti Jacobs Family Trust, over which Mr. Jacobs has voting control via a 2007 shareholders agreement. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3)   | The address for Mr. Bloom is 31 N. Suffolk Lane, Lake Forest, Illinois 60045. Mr. Bloom does not own any shares of stock. However, he holds options to purchase 100,000 shares of our common stock. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4)   | The address for the Roberti Jacobs Family Trust is 31 N. Suffolk Lane, Lake Forest, Illinois 60045. The Roberti Jacobs Family Trust irrevocably conveyed all of its voting power to Gerard M. Jacobs pursuant to the 2007 shareholder agreement described above. Mr. Jacobs is one of the grantors of the trust corpus, Mr. Jacobs’ mother in law Joan B. Roberti is the trustee, and Mr. Jacobs’ children are the beneficiaries. The trust is irrevocable. The Trust’s 4,666,497 shares consist of (a) 1,166,497 shares owned, and (b) 3,500,000 warrants owned at $0.10 per share. The Trust has the right, for 90 days after the closing of the Cogility merger, to invest an additional $350,000 into the Company in accordance with the private placement in which it participated, and if it does so, it will acquire an additional 3,500,000 warrants at $0.10 per share. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (5)   | The address for Mr. Greene is 6 Joliet Drive, Coto de Caza, California 92679. Mr. Greene does not own any shares of stock. However, he holds options and warrants to purchase a total of 350,000 shares of our common stock, consisting of (a) 100,000 options at $0.10 per share, the vesting of which is contingent upon the closing of the merger with Cogility, and (b) 250,000 warrants at $0.10 per share. Mr. Greene has the right, for 90 days after the closing of the Cogility merger, to invest an additional $25,000 into the Company in accordance with the private placement in which he participated, and if he does so, he will acquire an additional 250,000 warrants at $0.10 per share. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6)   | The address for Mr. McCaffrey is 31 N. Suffolk Lane, Lake Forest, Illinois 60045. Mr. McCaffrey does not own any shares of stock. However, he holds options to purchase 100,000 shares of our common stock. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (7)   | The address for Mr. Morrissy is 31 N. Suffolk Lane, Lake Forest, Illinois 60045. Mr. Morrissy does not own any shares of stock. However, he holds options to purchase 100,000 shares of our common stock. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8)   | The address for Mr. Mesolella is 27 Paddock Drive, Lincoln, Road Island 02865. Mr. Mesolella does not own any shares of stock. However, he holds options and warrants to purchase a total of 350,000 shares of our common stock, consisting of (a) 100,000 options at $0.10 per share, the vesting of which is contingent upon the closing of the merger with Cogility, and (b) 250,000 warrants at $0.10 per share. Mr. Mesolella has the right, for 90 days after the closing of the Cogility merger, to invest an additional $25,000 into the Company in accordance with the private placement in which he participated, and if he does so, he will acquire an additional 250,000 warrants at $0.10 per share. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (9)   | The address for Mr. Keller is 25991 W. Herman Ave., Antioch, IL 60002. Mr. Keller does not own any shares of stock. However, he holds warrants to purchase a total of 3,000,000 common stock shares, consisting of (a) 2,500,000 warrants at $0.10 per share, and (b) one of his affiliates, Glendenning Capital, Inc., has 500,000 warrants at $0.10 per share.  Mr. Keller has the right, for 90 days after the closing of the Cogility merger, to invest an additional $250,000 into the Company in accordance with the private placement in which he participated, and if he does so, he will acquire an additional 2,500,000 warrants at $0.10 per share. Also, Glendenning Capital, Inc. has the right, for 90 days after the closing of the Cogility merger, to invest an additional $50,000 into the Company in accordance with the private placement in which it participated and if it does so, it will acquire an additional 500,000 warrants at $0.10 per share. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (10)   | The address for the Heiders is 1100 Queen Anne Road, Woodstock, Illinois 60098. The Heiders do not own any shares of stock. However, they hold warrants to purchase a total of 1,500,000 common stock shares at $0.10 per share. The Heiders have the right, for 90 days after the closing of the Cogility merger, to invest an additional $150,000 into the Company in accordance with the private placement in which they participated, and if they do so, they will acquire an additional 1,500,000 warrants at $0.10 per share. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (11)   | Gerard M. Jacobs has rights to vote the shares of the Roberti Jacobs Family Trust and L. Dee Hall. These shares have not been applied as beneficially owned by both Mr. Jacobs and the respective stockholders, but not counted more than once in the total column. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Equity Compensation Plan Information                         |
|--------------------------------------------------------------|
|                                                         |   |   |   |
|   Plan Category                                         |   Number of securities to be issued upon exercise of outstanding options, warrants and rights |   Weighted-average exercise price of outstanding options, warrants and rights |   Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
| Equity compensation plans approved by security holders  | 12,600,000(1) | $0.06 | 1,117,925(2) |
|                                                         |
| Equity compensation plans not approved by security holders   | - | - | - |
| Total                                                        | 12,600,000(3)(4) | $0.06 | 1,117,925(5) |
|                                                         | - | - |   |

| 1.   | In November 2010, Acquired Sales granted these stock options to the members of management that participated in structuring the financing and the merger with Cogility. Those stock options were for the purchase of 12,600,000 pre-split common shares at $0.10 per share, or 630,000 post-split common shares at $2.00 per share. The options vest upon the occurrence of the merger, which as of the date of this filing, has not occurred. The grant-date fair value of these stock options of $801,762 less $308,787 already included in Acquired Sales’ operations is recognized as compensation expense. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.   | Prior to the merger, Cogility had stock options outstanding that permit the holders thereof to purchase 5,925,000 Cogility common shares at prices ranging from $0.001 to $1.40 per share. In the merger transaction, the Cogility option holders are to exchange these stock options for 1,117,925 Acquired Sales stock options exercisable at prices ranging from $0.001 to $5.00 per share. The exchange of these stock options is considered to be part of the recapitalization of Cogility and is not a modification of the Cogility stock options. There are 3,295,000 of these Cogility stock options that are exchangeable for 621,698 Acquired Sales stock options that vested during 2011 upon Acquired Sales obtaining at least $500,000 of financing and the remaining Cogility stock options vest upon occurrence of the merger with the Acquired Sales subsidiary. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | Gerard M. Jacobs is the only executive officer of the Company. He has received 12,100,000 options. |
|----------------|----------------------------------------------------------------------------------------------------|

| 4.   | The current directors who are not executive officers have collectively received 500,000 options. |
|----------------|--------------------------------------------------------------------------------------------------|

| 5.   | Of the 1,117,925 Cogility options, Gerard M. Jacobs holds options that are to be exchanged for 571,698 Acquired Sales options should the acquisition of Cogility be completed. This would increase the number of post-reverse split Acquired Sales options held by Mr. Jacobs to 1,176,698 from 605,000 presently held. Roger S. Greene and Vincent J. Mesolella each hold Cogility options that are to be exchanged for 25,000 Acquired Sales options should the acquisition of Cogility be completed. This would increase the number of post-reverse split Acquired Sales options held by each of Mr. Greene and Mr. Mesolella to 30,000 from 5,000 presently held. |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| Form 10-SB3.13.23.33.43.53.6 | March 23, 2007Articles of Incorporation dated December 12, 1985Amended Articles of Incorporation Dated July 1992Amended Articles of Incorporation Dated November 1996Amended Articles of Incorporation Dated June 1999Amended Articles of Incorporation Dated January 25, 2006Amended Bylaws |
|------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Form 8-K5.01 | August 2, 2007Shareholder Agreement |
|--------------|-------------------------------------|

| Form 10Q10.110.210.310.410.510.6 | May 18, 2009Private Merchant Banking Agreement-Anniston Capital, Inc.Warrant Agreement #1-Anniston Capital, Inc.Warrant Agreement #2-Anniston Capital, Inc.$100,000 Promissory Note – December 1, 2007$10,000 Promissory Note – January 30, 2008$10,000 Promissory Note – November 9, 2008 |   |
|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| Form 10-K10.7  | August 20, 2010$4,000 Promissory Note – April 19, 2010  |   |
|---------------------|--------------------------------------------------------------------|--------|

----

| Form 8-K10.199.1 | November 5, 2010Letter of Intent Agreement Cogility Software dated November 4, 2010Press Release |
|------------------|--------------------------------------------------------------------------------------------------|
| Form 10-K10.8 | December 17, 2010$20,000 Promissory Note – October 12, 2010 |
|---------------|-------------------------------------------------------------------|

| This Form 10-K4.14.210.1031.1   32.1  |  Form of Note 3%Form of WarrantSubscription AgreementCertification of principal executive officer and principal financial officerpursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, asamended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Actof 2002 executed by Gerard M. JacobsCertification of principal executive officer and principal financial officerpursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002 executed by Gerard M. Jacobs |
|-----------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----